What is the prevalence of Didelphys uterus?

Didelphys uterus is a rare congenital uterine anomaly estimated to affect approximately 0.1% to 0.5% of the general female population, though true prevalence is likely higher due to asymptomatic cases. Because many individuals with didelphys uterus never experience symptoms, the condition is frequently underdiagnosed and often discovered only during routine gynecological screenings or infertility investigations.

What is the estimated prevalence of didelphys uterus?

The prevalence of didelphys uterus is difficult to pinpoint exactly because it is often asymptomatic. Clinical literature, including data from the NIH Genetic and Rare Diseases Information Center (GARD), suggests that uterine anomalies as a whole occur in roughly 3-5% of the general population, with didelphys uterus representing a smaller subset of these cases, estimated at approximately 0.1% to 0.5%. It is important to note that these figures are based on clinical populations and may not reflect the true prevalence in the general population, as many women remain undiagnosed throughout their lives.

How does didelphys uterus affect different populations and demographics?

As a condition involving the development of the Müllerian ducts, didelphys uterus exclusively affects individuals assigned female at birth. There is no known geographic or ethnic predilection for the condition, though it is categorized as a rare congenital anomaly. Regarding age of onset, the condition is present from birth (congenital), but it is typically identified during adolescence—often when menstruation begins and clinical symptoms like dysmenorrhea (painful periods) or hematocolpos (blood trapped in a hemivagina) occur—or during adulthood when attempting to conceive.

Why is accurate data for didelphys uterus challenging to obtain?

The primary challenge in establishing accurate prevalence for didelphys uterus is that the condition often does not cause health complications. Many individuals with this anatomy have successful pregnancies and normal menstrual cycles, meaning they may never undergo the imaging (such as MRI or 3D ultrasound) required for a formal diagnosis. Consequently, the condition is likely significantly underreported in medical literature. At DiseaseMaps.org, we have seen 60 individuals join our community to share their lived experiences, which highlights that while didelphys uterus is considered rare, patient-led platforms are vital for understanding the true scope of the condition beyond textbook definitions.

What factors contribute to the diagnosis of didelphys uterus?

While many people live without knowing they have this anatomy, clinical diagnosis usually occurs following specific health events. Common indicators that lead to a formal diagnosis include:

• Reproductive challenges: Recurrent pregnancy loss or preterm labor investigations.


• Gynecological pain: Severe dysmenorrhea or pelvic pain caused by obstructed hemivagina.


• Incidental findings: Discovery during routine pelvic ultrasounds for unrelated health matters.


• Anatomical variations: Often accompanied by a longitudinal vaginal septum or renal anomalies (such as unilateral renal agenesis).

Next steps

• Consult a reproductive endocrinologist or a gynecologist specializing in Müllerian duct anomalies if you suspect you have didelphys uterus.


• Request a 3D ultrasound or pelvic MRI, which are the gold standards for visualizing uterine morphology.


• Join the community at DiseaseMaps.org to connect with others who have navigated similar diagnostic and reproductive journeys.


• Keep a detailed log of your menstrual cycles and any pelvic pain to share with your healthcare provider during your consultation.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Uterus didelphys overview.


• Orphanet: Rare diseases and congenital malformations of the female genital tract.


• OMIM (Online Mendelian Inheritance in Man): Database entry for Müllerian duct anomalies.


• PubMed Central: Clinical review of the prevalence and reproductive outcomes of uterine anomalies.